Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Journal of Clinical Oncology

Germline sequence variation in Rwandan patients with breast and prostate cancer.

View Full Paper
Ask AI
Bookmark
Share

Authors

AMAchille ManirakizaTFTemidayo FadeluSBShakuntala Baichoo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Manirakiza et al. (2024) studied this question.

synapsesocial.com/papers/68e66f08b6db6435875fa54ehttps://doi.org/10.1200/jco.2024.42.16_suppl.10591
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Uptake of germline genetic testing in patients with advanced breast, ovarian, pancreatic, or prostate cancer.2024
  2. 2Germline gene-specific associations in a large prostate cancer cohort.2024 · 1 citations
  3. 3Embedding germline genetic testing into African oncology care: Early results from the Genetic Cancer Families (GenCAF) program.2026
  4. 4Abstract 6289: Targeted sequencing of common cancer susceptibility genes reveals germline variants in African prostate cancer patients.2026
  5. 5Implementation of Universal Pan-Cancer Germline Genetic Testing in an Arab Population: The Jordanian Exploratory Cancer Genetics Study2024 · 2 citations